Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SunCar Technology Group Inc. Joins the Prestigious NASDAQ Golden Dragon China Index 2024-11-19 21:45
Nature's Miracle Holding Inc. Announces 1-for-30 Reverse Stock Split 2024-11-19 21:30
X Financial to Report Third Quarter 2024 Financial Results on November 27, 2024 2024-11-19 21:27
Pop Culture Announces Improvement in Overall Operations During the Fiscal Year Ended June 30, 2024 2024-11-19 21:00
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study 2024-11-19 20:30
Baijiayun Contributes to the "Urban and Rural School Community" Project, Empowering an Infinite Future for Smart Education 2024-11-19 19:28
Mega Matrix Announced that the English Version of Short Drama "When My Son Choose His Wife" Premiered on FlexTV on November 19 2024-11-19 18:30
Vipshop Reports Unaudited Third Quarter 2024 Financial Results 2024-11-19 18:00
Noah to Host Corporate Open Day on December 6, 2024, in Hong Kong 2024-11-19 17:35
Weibo Announces Third Quarter 2024 Unaudited Financial Results 2024-11-19 17:15
Gaotu Techedu to Report Third Quarter 2024 Financial Results on December 4, 2024 2024-11-19 16:00
Hyundai Mobis Outlines Value-Up Strategy at CEO Investor Day 2024-11-19 14:15
Zepp Health Corporation Reports Third Quarter 2024 Unaudited Financial Results 2024-11-19 09:00
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player 2024-11-19 08:00
FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results 2024-11-19 06:00
Trip.com Group Limited Reports Unaudited Third Quarter of 2024 Financial Results 2024-11-19 06:00
Tuya Reports Third Quarter 2024 Unaudited Financial Results 2024-11-19 05:05
Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Convergence 2024 2024-11-19 02:15
Shengfeng Development Limited Announces Joint Venture with Fujian Fulai Aviation to Expand Low-Altitude Logistics Services 2024-11-18 22:15
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC 2024-11-18 22:00
1 2 3 4 5 2222